Diagnosis and management of giant cell arteritis: Major review
Authors:
- 10 January 2021
- journal article
- review article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 49 (2) , 169-185
Abstract
Giant cell arteritis is a medical emergency because of the high risk of irreversible blindness and cerebrovascular accidents. While elevated inflammatory markers, temporal artery biopsy and modern imaging modalities are useful diagnostic aids, thorough history taking and clinical acumen still remain key elements in establishing a timely diagnosis. Glucocorticoids are the cornerstone of treatment but are associated with high relapse rates and side effects. Targeted biologic agents may open up new treatment approaches in the future.Keywords
This publication has 179 references indexed in Scilit:
- Clinicopathologic Correlations in Giant Cell ArteritisOphthalmology, 2009
- Giant Cell Arteritis Presenting with Cotton Wool SpotsSeminars in Ophthalmology, 2008
- Poor Prognosis of Visual Outcome after Visual Loss from Giant Cell ArteritisOphthalmology, 2005
- Partial facial paralysis following temporal artery biopsyEye, 2000
- Severe anemia as the presenting manifestation of giant cell arteritisArthritis & Rheumatism, 1995
- Giant cell arteritis in Iceland.Arthritis & Rheumatism, 1994
- Anterior ischaemic optic neuropathy Differentiation of arteritic from non-arteritic type and its managementEye, 1990
- The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumaticaArthritis & Rheumatism, 1981
- Presentation of occult giant cell arteritisArthritis & Rheumatism, 1980
- Giant‐cell (temporal) arteritisThe Journal of Pathology and Bacteriology, 1954